Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 22.2B | 17.8B | 18.1B | 18.1B |
Cost of revenue | 17.8B | 14.6B | 15.2B | 14.9B |
Gross profit | 4.3B | 3.3B | 2.9B | 3.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.6B | 1.3B | 1.1B | 1.3B |
Operating income | 1.8B | 927.4M | 683.1M | 787.5M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 154.9M | 161.6M | 156.3M | 116.1M |
Other income expense | — | — | — | — |
Pretax income | 1.7B | 904.6M | 596.7M | 861.4M |
Tax provision | 440.5M | 218.8M | 101.4M | 217.7M |
Net income | 1.3B | 685.7M | 495.3M | 643.8M |
Basic EPS | — | 6.1 | 4.4 | 5.7 |
Diluted EPS | — | 6.1 | 4.4 | 5.7 |
Basic average shares | — | 113.0M | 112.8M | 112.7M |
Diluted average shares | — | 113.0M | 113.1M | 113.1M |
EBITDA | 2.1B | 1.2B | 927.8M | 1.1B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |